(Q33406570)

26 July 2017

title

The use of eculizumab in renal transplantation (English)

1 reference

26 July 2017

Anthony Dorling

5

0 references

author name string

A Nicholas R Barnett

1

1 reference

26 July 2017

Elham Asgari

2

1 reference

26 July 2017

Paramit Chowdhury

3

1 reference

26 July 2017

Steven H Sacks

4

1 reference

26 July 2017

Nizam Mamode

6

1 reference

26 July 2017

publication date

21 March 2013

1 reference

26 July 2017

published in

Clinical Transplantation

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

E216-29

1 reference

The complement system in regulation of adaptive immunity

26 July 2017

cites work

1 reference

Complement and renal transplantation: from donor to recipient

21 January 2018

1 reference

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 January 2018

1 reference

Complement in organ transplantation.

21 January 2018

1 reference

Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.

21 January 2018

1 reference

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy

21 January 2018

1 reference

Accommodation: preventing injury in transplantation and disease

21 January 2018

1 reference

Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report

21 January 2018

1 reference

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation

21 January 2018

1 reference

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

21 January 2018

1 reference

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

21 January 2018

1 reference

Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy

21 January 2018

1 reference

Clinical grand rounds: atypical hemolytic uremic syndrome

21 January 2018

1 reference

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

21 January 2018

1 reference

Eculizumab for dense deposit disease and C3 glomerulonephritis

21 January 2018

1 reference

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

21 January 2018

1 reference

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access

21 January 2018

1 reference

Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.

21 January 2018

1 reference

Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report

21 January 2018

1 reference

Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation

21 January 2018

1 reference

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome

21 January 2018

1 reference

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

21 January 2018

1 reference

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein

21 January 2018

1 reference

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

Eculizumab and renal transplantation in a patient with CAPS

21 January 2018

1 reference

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy

21 January 2018

1 reference

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CTR.12102

1 reference

26 July 2017

1 reference